Partial hepatectomy for liver metastases from nasopharyngeal carcinoma: a comparative study and review of the literature

por Huang, Jun, Li, Qijiong, Zheng, Yun, Shen, Jingxian, Li, Binkui, Zou, Ruhai, Wang, Jianping, Yuan, Yunfei
Publicado 2014

Resection versus Resection with Preoperative Transcatheter Arterial Chemoembolization for Resectable Hepatocellular Carcinoma Recurrence

por Tao, Qiang, He, Wei, Li, Binkui, Zheng, Yun, Zou, Ruhai, Shen, Jingxian, Liu, Wenwu, Zhang, Yuanping, Yuan, Yunfei
Publicado 2018

Impact of follow-up interval on patients with hepatocellular carcinoma after curative ablation

por Liu, Wenwu, Zheng, Yun, Zou, Ruhai, Shen, Jingxian, He, Wei, Yang, Zhiwen, Zhang, Yuanping, Li, Binkui, Yuan, Yunfei
Publicado 2018

Clinical features and outcome of multiple primary malignancies involving hepatocellular carcinoma: A long-term follow-up study

por Zeng, Qing-An, Qiu, Jiliang, Zou, Ruhai, Li, Yijie, Li, Shengping, Li, Binkui, Huang, Pinzhu, Hong, Jian, Zheng, Yun, Lao, Xiangming, Yuan, Yunfei
Publicado 2012

Long Noncoding RNA Expression Signatures of Metastatic Nasopharyngeal Carcinoma and Their Prognostic Value

por Zhang, Wei, Wang, Lin, Zheng, Fang, Zou, Ruhai, Xie, Changqing, Guo, Qiannan, Hu, Qian, Chen, Jianing, Yang, Xing, Yao, Herui, Song, Erwei, Xiang, Yanqun
Publicado 2015

Long- versus short-interval follow-up after resection of hepatocellular carcinoma: a retrospective cohort study

por He, Wei, Zheng, Yun, Zou, Ruhai, Shen, Jingxian, Yang, Junping, Qiu, Jiliang, Tao, Qiang, Liu, Wenwu, Yang, Zhiwen, Zhang, Yuanping, Li, Binkui, Yuan, Yunfei
Publicado 2018

Conversion to Resectability Using Transarterial Chemoembolization Combined With Hepatic Arterial Infusion Chemotherapy for Initially Unresectable Hepatocellular Carcinoma

por Li, Binkui, Qiu, Jiliang, Zheng, Yun, Shi, Yunxing, Zou, Ruhai, He, Wei, Yuan, Yichuang, Zhang, Yuanping, Wang, Chenwei, Qiu, Zhiyu, Li, Kai, Zhong, Chengrui, Yuan, Yunfei
Publicado 2021

The role of clinically significant portal hypertension in hepatic resection for hepatocellular carcinoma patients: a propensity score matching analysis

por He, Wei, Zeng, Qingli, Zheng, Yun, Chen, Meixian, Shen, Jingxian, Qiu, Jiliang, Chen, Miao, Zou, Ruhai, Liao, Yadi, Li, Qijiong, Wu, Xianqiu, Li, Binkui, Yuan, Yunfei
Publicado 2015

Resection vs Ablation for Multifocal Hepatocellular Carcinomas meeting the Barcelona-Clinic Liver Cancer A Classification: A Propensity Score Matching Study

por Liu, Wenwu, Yang, Zhiwen, Zou, Ruhai, Qiu, Jiliang, Shen, Jingxian, Liao, Yadi, Wang, Chenwei, Zhang, Yuanping, Wang, Yongjin, Yuan, Yichuan, Li, Kai, Zuo, Dinglan, He, Wei, Zheng, Yun, Li, Binkui, Yuan, Yunfei
Publicado 2019

Microwave ablation versus resection for hepatocellular carcinoma within the Milan criteria: a propensity-score analysis

por Liu, Wenwu, Zou, Ruhai, Wang, Chenwei, Qiu, Jiliang, Shen, Jingxian, Liao, Yadi, Yang, Zhiwen, Zhang, Yuanping, Wang, Yongjin, Yuan, Yichuan, Li, Kai, Zuo, Dinglan, He, Wei, Zheng, Yun, Li, Binkui, Yuan, Yunfei
Publicado 2019

Predictive factors for the benefit of triple‐drug transarterial chemoembolization for patients with unresectable hepatocellular carcinoma

por He, MinKe, Li, Qing, Shen, JingXian, Tan, GuoSheng, Li, QiJiong, Lai, JiaYing, Wei, Wei, Zhang, YaoJun, Zou, RuHai, Chen, MinShan, Guo, RongPing, Shi, Ming
Publicado 2019